^
Contact us to learn more about
our Premium Content: News alerts, weekly reports and conference plannersDRUG:
rondecabtagene autoleucel (LYL314)
i
Other names: LYL314, IMPT-314, IMPT314, IMPT 314, LYL-314, ronde-cel
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Company:
Lyell Immunopharma
Drug class:
CD19-targeted CAR-T immunotherapy, CD20-targeted CAR-T immunotherapy
Related drugs:
